SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus receives USFDA approval for initiating Phase I clinical trials of ‘ZYDPLA1’

23 Oct 2013 Evaluate

Zydus Cadila, an innovative global pharmaceutical company, has received an approval for Phase I clinical trial from the USFDA for ZYDPLA1 - a next generation, long-acting DPP-4 Inhibitor. ZYDPLA1 is an orally active, small molecule NCE, discovered and developed by the Zydus Research Centre, the NCE research wing of Zydus.

ZYDPLA1 is a novel compound in the Gliptin class of anti-diabetic agents. It works by blocking the enzyme Dipeptidyl Peptidase-4 (DPP-4), which inactivate the Incretin hormone GLP-1.

Currently, all available DPP-4 inhibitors are dosed once-daily, ZYDPLA1 with a once-a-week dosing regimen, would provide diabetic patients with a more convenient treatment alternative, ZYDPLA1 will offer sustained action, which will result, in an improved efficacy profile.

Zydus Lifesciences Share Price

945.05 5.85 (0.62%)
17-Apr-2026 11:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.10
Dr. Reddys Lab 1222.90
Cipla 1239.65
Zydus Lifesciences 945.05
Lupin 2320.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×